Vestcor Inc’s Pacira BioSciences PCRX Stock Holding History

Vestcor Inc’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,681	Closed	-$174K	–	1226
2026 Q1	$174K	Buy	7,681 +4,177	+119%	+$92.8K	﹤0.01%	1056
2025 Q4	$91K	Hold	3,504	–	–	﹤0.01%	1069
2025 Q3	$90K	Buy	+3,504	New	+$86.1K	﹤0.01%	1100
2025 Q1	–	Sell	-3,459	Closed	-$65K	–	1251
2024 Q4	$65K	Hold	3,459	–	–	﹤0.01%	1129
2024 Q3	$52K	Hold	3,459	–	–	﹤0.01%	1095
2024 Q2	$99K	Hold	3,459	–	–	﹤0.01%	1058
2024 Q1	$101K	Hold	3,459	–	–	﹤0.01%	1095
2023 Q4	$117K	Hold	3,459	–	–	﹤0.01%	1072
2023 Q3	$106K	Buy	+3,459	New	+$125K	﹤0.01%	1109
2023 Q1	–	Sell	-1,441	Closed	-$56K	–	1241
2022 Q4	$56K	Hold	1,441	–	–	﹤0.01%	1116
2022 Q3	$77K	Buy	+1,441	New	+$80.1K	﹤0.01%	1110
2022 Q1	–	Sell	-1,202	Closed	-$72K	–	1508
2021 Q4	$72K	Sell	1,202 -136	-10%	-$7.5K	﹤0.01%	1099
2021 Q3	$75K	Hold	1,338	–	–	﹤0.01%	1044
2021 Q2	$81K	Hold	1,338	–	–	﹤0.01%	1072
2021 Q1	$94K	Hold	1,338	–	–	﹤0.01%	950
2020 Q4	$80K	Hold	1,338	–	–	﹤0.01%	880
2020 Q3	$80K	Hold	1,338	–	–	﹤0.01%	786
2020 Q2	$70K	Buy	+1,338	New	+$55.9K	﹤0.01%	744

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vestcor Inc's PCRX Position: Q2 2026 in Review

Vestcor Inc sold out of Pacira BioSciences (PCRX) in Q2 2026, closing a stake of 7,681 shares — an estimated $174K sold.

Vestcor Inc first reported a position in PCRX in Q2 2020 and held it in 18 quarters. The position peaked at $174K in Q1 2026. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Vestcor Inc reported no remaining Pacira BioSciences position as of Q2 2026 after selling out during the quarter.
Vestcor Inc sold 7,681 Pacira BioSciences shares in Q2 2026, an estimated $174K.
Vestcor Inc first reported a position in Pacira BioSciences in Q2 2020 and held it in 18 quarters.
Vestcor Inc's Pacira BioSciences position peaked at $174K in Q1 2026.
254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.